The Rediscovery of Hydroxychloroquine in Allergic Diseases in the COVID-19 Era
J. investig. allergol. clin. immunol
; J. investig. allergol. clin. immunol. (Internet);31(1): 85-86, 2021.
Article
in En
| IBECS
| ID: ibc-202266
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
No disponible
Full text:
1
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Antiviral Agents
/
Conjunctivitis, Allergic
/
Rhinitis, Allergic, Seasonal
/
Treatment Outcome
/
Coronavirus Infections
/
Anti-Allergic Agents
/
Post-Exposure Prophylaxis
/
Hydroxychloroquine
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
J. investig. allergol. clin. immunol
/
J. investig. allergol. clin. immunol. (Internet)
Year:
2021
Document type:
Article